Cerebrovascular miRNAs Track Early Development of Alzheimer’s Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-230300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Phoebe P Chum und 3 weiteren Autor:innen. Beteiligte Einrichtung: Basic Sciences, Loma Linda University, Loma Linda, CA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs, Mice, Transgenic, Cerebrovascular Circulation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is associated with impaired cerebral circulation which underscores diminished delivery of blood oxygen and nutrients to and throughout the brain. In the 3xTg-AD mouse model, we have recently found that > 10 cerebrovascular miRNAs pertaining to vascular permeability, angiogenesis, and inflammation (e.g., let-7d, miR-99a, miR-132, miR-133a, miR-151-5p, and miR-181a) track early development of AD. Further, endothelial-specific miRNAs (miR-126-3p, miR-23a/b, miR-27a) alter with onset of overall AD pathology relative to stability of smooth muscle/pericyte-specific miRNAs (miR-143, miR-145).
Objective
We tested the hypothesis that cerebrovascular miRNAs indicating AD pathology share mRNA targets that regulate key endothelial cell functions such as angiogenesis, vascular permeability, and blood flow regulation.
Methods
As detected by NanoString nCounter miRNA Expression panel for 3xTg-AD mice, 61 cerebrovascular miRNAs and respective mRNA targets were examined using Ingenuity Pathway Analysis for canonical Cardiovascular (Cardio) and Nervous System (Neuro) Signaling.
Results
The number of targets regulated per miRNA were 21±2 and 33±3 for the Cardio and Neuro pathways respectively, whereby 14±2 targets overlap among pathways. Endothelial miRNAs primarily target members of the PDE, PDGF, SMAD, and VEGF families. Individual candidates regulated by≥4 miRNAs that best mark AD pathology presence in 3xTg-AD mice include CFL2, GRIN2B, PDGFB, SLC6A1, SMAD3, SYT3, and TNFRSF11B. Conclusion: miRNAs selective for regulation of endothelial function and respective downstream mRNA targets support a molecular basis for dysregulated cerebral blood flow regulation coupled with enhanced cell growth, proliferation, and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Basic Sciences, Loma Linda University, Loma Linda, CA, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Chum, P. P., Bishara, M. A., Solis, S. R., & Behringer, E. J. (2024). Cerebrovascular miRNAs Track Early Development of Alzheimer’s Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230300
Vancouver
Chum PP, Bishara MA, Solis SR, Behringer EJ. Cerebrovascular miRNAs Track Early Development of Alzheimer’s Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-230300
BibTeX
@article{Chum2024,
author = {Chum, Phoebe P and Bishara, Mary A and Solis, Summer R and Behringer, Erik J},
title = {Cerebrovascular miRNAs Track Early Development of Alzheimer’s Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-230300}
}
EUVIMED